Glazer Capital LLC’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Glazer Capital LLC’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-69,410	Closed	-$22M	–	153
2023 Q4	$22M	Buy	+69,410	New	+$13.5M	2.26%	11

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Glazer Capital LLC's KRTX Position: Q1 2024 in Review

Glazer Capital LLC sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 69,410 shares — an estimated $22M sold.

Glazer Capital LLC first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $22M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Glazer Capital LLC reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Glazer Capital LLC sold 69,410 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $22M.
Glazer Capital LLC first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Glazer Capital LLC's Karuna Therapeutics, Inc. Common Stock position peaked at $22M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Glazer Capital LLC's 13F filing for Q1 2024, filed 15 May 2024.